Predicting stroke treatment success with a blood test
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies a blood marker called sTREM to see if it can help predict outcomes after a mechanical clot removal procedure (endovascular thrombectomy) for large-vessel stroke. If you have had a stroke due to a large artery blockage within the last 24 hours and plan to have this procedure, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You had a stroke caused by a blockage in a large artery.
- Your stroke symptoms started less than 24 hours ago.
- You are scheduled for a procedure to remove the clot (endovascular thrombectomy).
- You or a relative can agree to participate by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests taken after a mechanical thrombectomy (a procedure to remove a blood clot from the brain) can help predict how well a patient will recover from a stroke. The goal is to find early signs that might guide future treatment and improve outcomes.
This study looks at patients having a stroke procedure to remove a clot. It aims to predict how well people recover. If you are having this treatment, the study might help doctors understand your likely outcome.
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests if a procedure to remove blood clots from brain arteries can help people who had a stroke more than 24 hours ago (up to 30 days). It aims to see if this treatment improves recovery for those with moderate to severe stroke symptoms.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.